Pascal Bamford

Company: Akoya Biosciences Inc.

Job title: Chief Clinical Officer

Seminars:

Progress on Multiplexed IHC CDx 5:15 pm

After long promise, multiplexing has matured from research to selection device driven by several late-stage clinical programs The combination of staining reagents and digital quantitation with advanced controls and calibrants have yielded systems that are highly reproducible and accurate This evolution has the potential to address the coming wave of new targeted ADC/IO therapies, positively…Read more

day: Day 1 - Track A (2)